TY - JOUR
AU - Uges,  D.
AB - Because accurate estimates of pharmacokinetic parameters were achieved, the four-point D-optimal sampling design may be very useful in future studies with MEN-10755.
TI - Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755
JF - Cancer Chemotherapy and Pharmacology
DO - 10.1007/s00280-004-0772-7
DA - 2004-07-01
UR - https://www.deepdyve.com/lp/springer-journals/development-of-an-optimal-sampling-strategy-for-clinical-90HFAaYX89
SP - 64
EP - 70
VL - 54
IS - 1
DP - DeepDyve
ER -